Prostate-specific antigen (PSA)

What a New PSMA PET/CT Study Reveals About Local PCa Treatment and High-Risk Recurrence

by

For the majority of patients at high-risk for biochemical recurrence of prostate cancer (PCa), new prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) research reaffirms a lack of sustained efficacy for monotherapy treatment with local radiation therapy or radical prostatectomy. For the retrospective study, recently published in BJUI Compass, researchers reviewed PSMA PET/CT data … Read more

Emerging Concepts and Recommendations for MRI in Prostate Cancer Screening

by

Should men with indeterminate magnetic resonance imaging (MRI) results refrain from getting a subsequent biopsy for prostate cancer (PCa)? Is staged MRI interpretation a viable option in PCa screening? Should MRI be a first-line option in the screening of patients for PCa? In a new review, recently published in the American Journal of Roentgenology, researchers … Read more